Guide for Primary Health Care Providers: Targeted
Tuberculin Testing and Treatment of Latent Tuberculosis Infection 2005
Return to Table of Contents
List of Abbreviations
A B
C D E
F G H I J K
L M N O
P Q R S
T U V W X Y Z
AFB
acid-fast bacilli
AIDS
acquired immune deficiency syndrome
ALT
alanine aminotransferase
APHL
American Public Health Laboratories
AST
aspartate aminotransferase
ATS
American Thoracic Society
BCG
bacille Calmette-Guérin
CDC
Centers for Disease Control and Prevention
DHP
delayed-type hypersensitivity
DOT
directly observed therapy
EMB
ethambutol
FDA
Food and Drug Administration
HAART
highly active antiretroviral therapies
HIV
human immunodeficiency virus
IFN-γ
interferon-gamma
INH
isoniazid
LTBI
latent TB infection
MDR TB
multidrug-resistant tuberculosis
MDR LTBI
multidrug-resistant latent TB infection
MMWR
Morbidity and Mortality Weekly Report
NNRTIs
nonnucleoside reverse transcriptase inhibitors
PI
protease inhibitors
PPD
purified protein derivative
PZA
pyrazinamide
QFT
QuantiFERON®-TB test and QuantiFERON®-TB
Gold test
RIF
rifampin
TB
tuberculosis
TNF-α
tumor necrosis factor-alpha
TST
tuberculin skin test
USPHS
U.S. Public Health Service
WHO
World Health Organization
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
|